Meet Merck’s Dealmaker: A Conversation With Roger Pomerantz

Merck’s new head of worldwide licensing and knowledge management Roger Pomerantz, MD, talks with IN VIVO about Merck’s business development strategy, whether biotech passion can exist on a Big Pharma scale, and the art of the deal.

On December 1, 2011, Merck & Co. Inc. introduced Roger Pomerantz, MD, as its new SVP and head, worldwide licensing and knowledge management.

Pomerantz replaces David Nicholson, PhD, the Organon and then Schering-Plough executive who had led business development at Merck since late...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business Strategy

More from In Vivo